Article Details

Avirmax Biopharma Announces First Patient Dosed in Clinical Trial of ABI-110, a ...

Retrieved on: 2024-11-21 23:49:08

Tags for this article:

Click the tags to see associated articles and topics

Avirmax Biopharma Announces First Patient Dosed in Clinical Trial of ABI-110, a .... View article details on hiswai:

Excerpt

HAYWARD, Calif., Nov. 21, 2024 /PRNewswire/ -- Avirmax Biopharma, Inc., a leader in the development of innovative gene therapies, today announced ...

Article found on: www.kilgorenewsherald.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo